[ad_1] For the treatment of hereditary amyloid transthyretin (hATTR), Ema Chmp has given the nod to the approval of patisiran, an experimental therapy that acts through the mechanism of RNA interference . …
Read More »Hereditary amyloidosis of transthyretin, free path from Chmp to pati
